These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 175023)

  • 41. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference.
    Miller G; Robinson J; Heston L; Lipman M
    IARC Sci Publ (1971); 1975; (11 Pt 1):395-408. PubMed ID: 190145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Epstein-Barr virus and EB virus infections in childhood.
    Andiman WA
    J Pediatr; 1979 Aug; 95(2):171-82. PubMed ID: 221638
    [No Abstract]   [Full Text] [Related]  

  • 43. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.
    Raab-Traub N; Dambaugh T; Kieff E
    Cell; 1980 Nov; 22(1 Pt 1):257-67. PubMed ID: 6253079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
    Wilmes E; Wolf H
    Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma.
    Nonoyama M; Huang CH; Pagano JS; Klein G; Singh S
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3265-8. PubMed ID: 4361687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma.
    Geser A; de Thé G; Lenoir G; Day NE; Williams EH
    Int J Cancer; 1982 Apr; 29(4):397-400. PubMed ID: 6282763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus genome in infectious mononucleosis.
    Pagano JS; Huang CH; Huang YT
    Nature; 1976 Oct; 263(5580):787-9. PubMed ID: 186715
    [No Abstract]   [Full Text] [Related]  

  • 50. Cross-neutralization of infectious mononucleosis and Burkitt lymphoma strains of Epstein-Barr virus with hyperimmune rabbit antisera.
    Coope D; Heston L; Brandsma J; Miller G
    J Immunol; 1979 Jul; 123(1):232-8. PubMed ID: 221591
    [No Abstract]   [Full Text] [Related]  

  • 51. Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant lymphoma.
    Abo W; Takada K; Kamada M; Imamura M; Motoya T; Iwanga M; Aya T; Yano S; Nakao T; Osato T
    Lancet; 1982 Jun; 1(8284):1272-6. PubMed ID: 6123020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.
    Desgranges C; De-Thé G; Ho JH; Ellouz R
    Int J Cancer; 1977 May; 19(5):627-33. PubMed ID: 193801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphoproliferative disease in a cotton-top marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus.
    Werner J; Wolf H; Apodaca J; zur Hausen H
    Int J Cancer; 1975 Jun; 15(6):1000-8. PubMed ID: 168158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan.
    Chao TY; Wang TY; Lee WH
    Cancer; 1997 Jul; 80(1):121-8. PubMed ID: 9210717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies to Epstein-Barr viral capsid and early antigens associated with Burkitt's lymphoma and lymphoblastic lymphosarcoma in Israel.
    Gotleib-Stematsky T; Ramot B; Vonsover B; Aghai E; Kende G; Ninio M; Modan M
    J Natl Cancer Inst; 1976 Apr; 56(4):721-3. PubMed ID: 233958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Burkitt's lymphoma].
    Gombos F; Serpico R; Femiano F
    Arch Stomatol (Napoli); 1984; 25(4):329-38. PubMed ID: 6100729
    [No Abstract]   [Full Text] [Related]  

  • 58. Unique pattern of Epstein-Barr virus specific antibodies in recurrent parotitis.
    Akaboshi I; Katsuki T; Jamamoto J; Matsuda I
    Lancet; 1983 Nov; 2(8358):1049-51. PubMed ID: 6138599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Structural organization of the Epstein-Barr virus genome].
    D'iachenko AG
    Eksp Onkol; 1984; 6(4):3-10. PubMed ID: 6209094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.